A Year-End Update Ahead Of Forecasts
Fevara (LSE:FVA), the Business formerly known as Carr's Group, has spent the past year narrowing its focus to livestock nutrition. On 30 September 2026 it issued a trading update for the year just ended, saying profit would be ahead of analysts' expectations. This article looks at what the company expects to report, what drove the improvement and what remains to be delivered.
A Focused Livestock Supplements Group
Fevara's shares trade on the Main Market of the London Stock Exchange under the code FVA. The group makes feed supplements for cattle and sheep, notably low moisture blocks that animals lick to supplement grazing, and operates in the UK, Europe, the United States and, since late 2025, Brazil. It also has joint venture interests in the US and Germany. Joshua Hoopes is chief executive, and the company has been listed in London since 1972.
The refocus was completed in August 2026. On 11 August, the company announced the disposal of Chirton Engineering, its last engineering business, leaving it as a pure livestock supplements group.
The 30 September Trading Update
For the year to 31 August 2026, Fevara said it expected Revenue of approximately £86 million, compared with £78.8 million in the previous year, representing like-for-like growth of 8%. Adjusted EBIT was expected to be about £6.0 million, up from £3.7 million, an increase of roughly 60%. The company noted that analyst consensus had been revenue of £86.3 million and adjusted EBIT of £5.5 million, so profit was expected to come in ahead while revenue was broadly in line.
It said its UK, European and US businesses had all performed well, with continued growth in low moisture block sales, and that Brazil had performed as expected following acquisition. Net Debt was about £2.0 million, which the company attributed to high cash conversion and asset disposals. Fevara also announced a new £20 million revolving Credit Facility with HSBC running to November 2028, with extension options, plus a £10 million uncommitted facility. Early trading in the new financial year was described as "encouraging and in line with expectations."
Building Blocks Of The Year
The interim results, published on 22 April 2026, showed the shape of the business. In the UK and Europe, low moisture block volumes rose 9% while lower-margin minerals volumes were deliberately reduced. In the US, southern states recorded solid Volume growth but northern states declined after an unusually warm winter reduced Demand for supplements. The company entered Brazil through the Macal Acquisition in December 2025 and bought a São Paulo production facility in March 2026, with production there planned to start in early 2027. In April 2026, it also signed a five-year distribution agreement with LithoNutri. The Interim Dividend was held at 1.2p per share.
Net cash at the half-year had fallen to £1.4 million from £15.7 million, reflecting the Brazil acquisitions and a tender offer, so the year-end net debt figure shows a modest move into borrowing. Chirton was sold for £0.65 million upfront plus £0.2 million deferred over two years.
Risks And Targets
Demand for supplements depends on weather, grazing conditions and farm incomes, as the northern US experience showed. Brazil is a new market and the São Paulo facility is not yet producing. The medium-term targets of £120 million of revenue, £15 million of adjusted EBITDA, a 10% adjusted EBIT Margin and 20% return on Capital employed are ambitions rather than forecasts. Audited figures may differ from the trading update.
Conclusion
Fevara expects to finish its financial year with adjusted EBIT of about £6.0 million, ahead of forecasts, driven by growth in low moisture blocks across the UK, Europe and the US. The full results will show whether the newly focused group can maintain that momentum as Brazil develops.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...